{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:36:46Z","timestamp":1788583006673,"version":"build-2803163510"},"reference-count":53,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T00:00:00Z","timestamp":1643155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>The human population is still facing appalling conditions due to several outbreaks of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) virus. The absence of specific drugs, appropriate vaccines for mutants, and knowledge of potential therapeutic agents makes this situation more difficult. Several 1, 2, 4-triazolo [1, 5-a] pyrimidine (TP)-derivative compounds were comprehensively studied for antiviral activities against RNA polymerase of HIV, HCV, and influenza viruses, and showed immense pharmacological interest. Therefore, TP-derivative compounds can be repurposed against the RNA-dependent RNA polymerase (RdRp) protein of SARS-CoV-2. In this study, a meta-analysis was performed to ensure the genomic variability and stability of the SARS-CoV-2 RdRp protein. The molecular docking of natural and synthetic TP compounds to RdRp and molecular dynamic (MD) simulations were performed to analyse the dynamic behaviour of TP compounds at the active site of the RdRp protein. TP compounds were also docked against other non-structural proteins (NSP1, NSP2, NSP3, NSP5, NSP8, NSP13, and NSP15) of SARS-CoV-2. Furthermore, the inhibition potential of TP compounds was compared with Remdesivir and Favipiravir drugs as a positive control. Additionally, TP compounds were analysed for inhibitory activity against SARS-CoV RdRp protein. This study demonstrates that TP analogues (monomethylated triazolopyrimidine and essramycin) represent potential lead molecules for designing an effective inhibitor to control viral replication. Furthermore, in vitro and in vivo studies will strengthen the use of these inhibitors as suitable drug candidates against SARS-CoV-2.<\/jats:p>","DOI":"10.3390\/molecules27030801","type":"journal-article","created":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T03:33:32Z","timestamp":1643168012000},"page":"801","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Computational Analysis Reveals Monomethylated Triazolopyrimidine as a Novel Inhibitor of SARS-CoV-2 RNA-Dependent RNA Polymerase (RdRp)"],"prefix":"10.3390","volume":"27","author":[{"given":"Anandakrishnan","family":"Karthic","sequence":"first","affiliation":[{"name":"Bioinformatics, DBT-National Institute of Animal Biotechnology (NIAB), Hyderabad 500032, India"},{"name":"Amity Institute of Biotechnology, Amity University Mumbai, Navi Mumbai 410206, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5778-6831","authenticated-orcid":false,"given":"Veerbhan","family":"Kesarwani","sequence":"additional","affiliation":[{"name":"Bioinformatics, DBT-National Institute of Animal Biotechnology (NIAB), Hyderabad 500032, India"},{"name":"Hap Biosolutions, Pvt. Ltd., Bhopal 462042, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3630-5706","authenticated-orcid":false,"given":"Rahul Kunwar","family":"Singh","sequence":"additional","affiliation":[{"name":"Cyano Biotech Lab, Department of Microbiology, School of Life Sciences, Hemvati Nandan Bahuguna Garhwal University, Srinagar (Garhwal) 246174, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavan Kumar","family":"Yadav","sequence":"additional","affiliation":[{"name":"Department of Veterinary Physiology and Biochemistry, Faculty of Veterinary and Animal Sciences, Banaras Hindu University, Mirzapur 231001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4265-9255","authenticated-orcid":false,"given":"Navaneet","family":"Chaturvedi","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cell Biology, Henry Wellcome Building, University of Leicester, Leicester LE1 7RH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5160-6673","authenticated-orcid":false,"given":"Pallavi","family":"Chauhan","sequence":"additional","affiliation":[{"name":"Department of Biology, Lund University, 22370 Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brijesh Singh","family":"Yadav","sequence":"additional","affiliation":[{"name":"Faculty of Biosciences and Aquaculture, Nord University, N-8049 Bod\u00f8, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep Kumar","family":"Kushwaha","sequence":"additional","affiliation":[{"name":"Bioinformatics, DBT-National Institute of Animal Biotechnology (NIAB), Hyderabad 500032, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1016\/S0140-6736(21)02758-6","article-title":"Omicron SARS-CoV-2 variant: A new chapter in the COVID-19 pandemic","volume":"398","author":"Karim","year":"2021","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"106054","DOI":"10.1016\/j.ijantimicag.2020.106054","article-title":"Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): A global pandemic and treatment strategies","volume":"56","author":"Sharma","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1126\/science.abc1560","article-title":"Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir","volume":"368","author":"Yin","year":"2020","journal-title":"Science"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1080\/09553002.2020.1818865","article-title":"A combinatorial approach of a polypharmacological adjuvant 2-deoxy-D-glucose with low dose radiation therapy to quell the cytokine storm in COVID-19 management","volume":"96","author":"Verma","year":"2020","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ijid.2021.03.015","article-title":"Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study","volume":"105","author":"Pandit","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/s41591-021-01397-4","article-title":"SARS-CoV-2 variants of concern are emerging in India","volume":"27","author":"Singh","year":"2021","journal-title":"Nat. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.drudis.2020.07.008","article-title":"Learning from history: Do not flatten the curve of antiviral research!","volume":"25","author":"Bobrowski","year":"2020","journal-title":"Drug Discov. Today"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat. Rev. Microbiol"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.cub.2020.03.022","article-title":"Probable pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak","volume":"30","author":"Zhang","year":"2020","journal-title":"Curr. Biol."},{"key":"ref_10","first-page":"100847","article-title":"Analysis of non-structural proteins, NSPs of SARS-CoV-2 as targets for computational drug designing","volume":"25","author":"Raj","year":"2021","journal-title":"Biochem. Biophys. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1073\/pnas.2003138117","article-title":"Cell entry mechanisms of SARS-CoV-2","volume":"117","author":"Shang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1002\/jmv.24678","article-title":"Zika viral polymerase inhibition using anti-HCV drugs both in market and under clinical trials","volume":"88","author":"Elfiky","year":"2016","journal-title":"J. Med. Virol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2217\/fvl-2017-0081","article-title":"Zika virus: Novel guanosine derivatives revealed strong binding and possible inhibition of the polymerase","volume":"12","author":"Elfiky","year":"2017","journal-title":"Future Virol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s12967-020-02439-0","article-title":"Analysis of SARS-CoV-2 RNA-dependent RNA polymerase as a potential therapeutic drug target using a computational approach","volume":"18","author":"Aftab","year":"2020","journal-title":"J. Transl. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1126\/science.1259210","article-title":"Structural basis for RNA replication by the hepatitis C virus polymerase","volume":"347","author":"Appleby","year":"2015","journal-title":"Science"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"22505","DOI":"10.1073\/pnas.1007626107","article-title":"Structural basis for active site closure by the poliovirus RNA-dependent RNA polymerase","volume":"107","author":"Gong","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1126\/science.abb7498","article-title":"Structure of the RNA-dependent RNA polymerase from COVID-19 virus","volume":"368","author":"Gao","year":"2020","journal-title":"Science"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s42269-020-00444-3","article-title":"Molecular targets and system biology approaches for drug repurposing against SARS-CoV-2","volume":"44","author":"Singh","year":"2020","journal-title":"Bull. Natl. Res. Cent."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0065-2725(07)95003-5","article-title":"Recent progress in 1, 2, 4-triazolo [1, 5-a] pyrimidine chemistry","volume":"95","author":"Fischer","year":"2007","journal-title":"Adv. Heterocycl. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ejmech.2019.01.027","article-title":"1, 2, 4-Triazolo [1, 5-a] pyrimidines in drug design","volume":"165","author":"Oukoloff","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1021\/acs.jafc.9b06006","article-title":"Discovery, structural optimization, and mode of Action of essramycin alkaloid and its derivatives as anti-tobacco mosaic virus and anti-phytopathogenic fungus agents","volume":"68","author":"Wang","year":"2019","journal-title":"J. Agric. Food Chem."},{"key":"ref_22","first-page":"5225","article-title":"Chemical profile of the antibacterial component from Leptolyngbya sp. HNBGU 002 isolated from a hot spring of Garhwal Himalaya","volume":"11","author":"Tyagi","year":"2020","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"W20","DOI":"10.1093\/nar\/gkh435","article-title":"BLAST: At the core of a powerful and diverse set of sequence analysis tools","volume":"32","author":"McGinnis","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1093\/bioinformatics\/bts565","article-title":"CD-HIT: Accelerated for clustering the next-generation sequencing data","volume":"28","author":"Fu","year":"2012","journal-title":"Bioinformatics"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1093\/nar\/22.22.4673","article-title":"CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice","volume":"22","author":"Thompson","year":"1994","journal-title":"Nucleic Acids Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"W350","DOI":"10.1093\/nar\/gky300","article-title":"DynaMut: Predicting the impact of mutations on protein conformation, flexibility and stability","volume":"46","author":"Rodrigues","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"W260","DOI":"10.1093\/nar\/gkz303","article-title":"NGPhylogeny. fr: New generation phylogenetic services for non-specialists","volume":"47","author":"Lemoine","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"W256","DOI":"10.1093\/nar\/gkz239","article-title":"Interactive Tree Of Life (iTOL) v4: Recent updates and new developments","volume":"47","author":"Letunic","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1021\/ci049794h","article-title":"Personal Experience with Four Kinds of Chemical Structure Drawing Software: Review on ChemDraw, ChemWindow, ISIS\/Draw, and ChemSketch","volume":"44","author":"Li","year":"2004","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e00950-20","DOI":"10.1128\/mSphere.00950-20","article-title":"Novel immune modulators enhance Caenorhabditis elegans Resistance to Multiple Pathogens","volume":"6","author":"Hummell","year":"2021","journal-title":"Msphere"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"D437","DOI":"10.1093\/nar\/gkaa1038","article-title":"RCSB Protein Data Bank: Powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences","volume":"49","author":"Burley","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41575-019-0227-6","article-title":"Building community in the gut: A role for mucosal serotonin","volume":"17","author":"Hoffman","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: Fast, Flexible and Free","volume":"26","author":"Lindahl","year":"2005","journal-title":"J. Comp. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1021\/ci300363c","article-title":"Automation of the CHARMM General Force Field (CGenFF) I: Bond perception and atom typing","volume":"52","author":"Vanommeslaeghe","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/ci500020m","article-title":"g_mmpbsa\u2014A GROMACS tool for high-throughput MM-PBSA calculations","volume":"54","author":"Kumari","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from COVID-19 virus and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"106012","DOI":"10.1016\/j.ijantimicag.2020.106012","article-title":"Computational screening of antagonists against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking","volume":"56","author":"Yu","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"104859","DOI":"10.1016\/j.phrs.2020.104859","article-title":"Candidate drugs against SARS-CoV-2 and COVID-19","volume":"157","author":"McKee","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Barage, S., Karthic, A., Bavi, R., Desai, N., Kumar, R., Kumar, V., and Lee, K.W. (2020). Identification and characterization of novel RdRp and Nsp15 inhibitors for SARS-CoV2 using computational approach. J. Biomol. Struct. Dyn., 1\u201318.","DOI":"10.1080\/07391102.2020.1841026"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12967-020-02344-6","article-title":"Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant","volume":"18","author":"Pachetti","year":"2020","journal-title":"J. Transl. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1021\/acs.jmedchem.5b00012","article-title":"A broad anti-influenza hybrid small molecule that potently disrupts the interaction of polymerase acidic protein\u2013basic protein 1 (PA-PB1) subunits","volume":"58","author":"Massari","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Mohammad, A., Al-Mulla, F., Wei, D.-Q., and Abubaker, J. (2021). Remdesivir MD Simulations Suggest a More Favourable Binding to SARS-CoV-2 RNA Dependent RNA Polymerase Mutant P323L Than Wild-Type. Biomolecules, 11.","DOI":"10.3390\/biom11070919"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ijid.2020.10.069","article-title":"Role of favipiravir in the treatment of COVID-19","volume":"102","author":"Joshi","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of COVID-19","volume":"383","author":"Beigel","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.3389\/fimmu.2021.725240","article-title":"Identification of Unique Peptides for SARS-CoV-2 Diagnostics and Vaccine Development by an In Silico Proteomics Approach","volume":"12","author":"Kesarwani","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.5808\/GI.2020.18.4.e44","article-title":"Spike protein D614G and RdRp P323L: The SARS-CoV-2 mutations associated with severity of COVID-19","volume":"18","author":"Biswas","year":"2020","journal-title":"Genom. Inform."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Liang, Q., Sun, C., Liu, H., Zhang, X., Ahmed, M.A., Misra, S., Uy, J.P.N., and Shaikh, M.B. (2021). Vaccination remains the first choice to control the spread of delta and other variants of severe acute respiratory coronavirus virus 2 (SARS-CoV-2). Infect. Control Hosp. Epidemiol., 1\u20132.","DOI":"10.1017\/ice.2021.364"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2174\/0929867328666210820114025","article-title":"Cordycepin as a Promising Inhibitor of SARS-CoV-2 RNA dependent RNA polymerase (RdRp)","volume":"29","author":"Bibi","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"59570","DOI":"10.1007\/s11356-021-16096-3","article-title":"Candidate antiviral drugs for COVID-19 and their environmental implications: A comprehensive analysis","volume":"28","author":"Biswas","year":"2021","journal-title":"Environ. Sci. Pollut. Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"110532","DOI":"10.1016\/j.biopha.2020.110532","article-title":"Safety profile of the antiviral drug remdesivir: An update","volume":"130","author":"Fan","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1021\/ci300367a","article-title":"admetSAR: A Comprehensive Source and Free Tool for Assessment of Chemical ADMET Properties","volume":"52","author":"Cheng","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"34033","DOI":"10.1039\/D0RA06424F","article-title":"Quinazoline-Schiff base conjugates: In silico study and ADMET predictions as multi-target inhibitors of coronavirus (SARS-CoV-2) proteins","volume":"10","author":"Mansour","year":"2020","journal-title":"RSC Adv."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/27\/3\/801\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:07:49Z","timestamp":1760134069000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/27\/3\/801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,26]]},"references-count":53,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["molecules27030801"],"URL":"https:\/\/doi.org\/10.3390\/molecules27030801","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,26]]}}}